About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
Private biopharmaceutical company focused on the development of therapies for retinal dystrophies.
Private biopharmaceutical company focused on the development of therapies for retinal dystrophies.
Sectors
Healthcare
Life Sciences
First Invested
2015
Early
Company Status
IPO/Acquired
NASDAQ: NITE
Acquired by Biogen